Anti-VEGF Receptor 1 antibody [Y103]
State & local contract award Virginia Awarded
- Contract number
- A207_PO-0472969
- Awardee
- Epitomics Inc
- Contracting organization
- University of Virginia
- Cumulative value
- $598.95
About this award
Epitomics Inc was awarded a contract by the University of Virginia on August 25, 2026, for the delivery of specialized biological research materials. The contract, identified as A207_PO-0472969, is valued at $598.95 and involves the procurement of Anti-VEGF (Vascular Endothelial Growth Factor) Receptor 1 antibody, catalog designation Y103. The single line item specifies delivery of one unit to Junping Hu at the University of Virginia in Virginia.
The deliverable comprises a monoclonal antibody targeting VEGF Receptor 1, a key component utilized in biomedical research applications. The contract represents a straightforward purchase order transaction for laboratory reagents, with no additional performance requirements or extended service obligations indicated in the available documentation. No contract period of performance beyond the award date has been specified in the contract materials provided.
Line items
| Item | Total |
|---|---|
| Anti-VEGF Receptor 1 antibody [Y103] | $598.95 |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A207_PO-0472969?
Contract A207_PO-0472969 was awarded to Epitomics Inc by University of Virginia on August 25, 2026.
How much is contract A207_PO-0472969 worth?
Its cumulative value is $598.95.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award